Online Automated Self-Hypnosis Program

Completed · Not applicable

Conditions studied: Smoking, Pain, Stress

In brief

After developing professional quality materials (audio) for an affordable automated self-hypnosis intervention program for facilitating smoking cessation, stress and pain reduction, researchers aim to gain qualitative reviews of this program, and test its initial feasibility and effects on smoking cessation and reduction in pain and stress. In addition, this study seeks to determine whether higher hypnotizability, as measured by the Hypnotic Induction Profile (assessed at baseline), is a moderator of improved outcome in these conditions.

Key facts

Study ID

NCT03931772

Run by

Stanford University

People needed

152

Starts

2017-09-05

Expected to finish

2022-02-25

Last updated by the study team

2023-03-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 18 years or older
• Able to read and understand English
• For the smokers, desire to quit smoking (specifically, report a motivation of ≥ 5 out of 10 to quit smoking on a 10-point Likert-type scale), and report being a daily smoker for at least one year, smoking an average ≥ 5 cigarettes per day
• For the pain group, report suffering from chronic pain syndromes, such as fibromyalgia or chronic low back pain
• For the stress group, report experiencing moderate to extreme stress or anxiety in the past month
• Having access to wireless internet connection or mobile data

You may not qualify if…

• Meeting criteria for drug abuse, including use of dissociative anesthetics, hallucinogens, opioids, cocaine, or amphetamine within the last 3 months
• Severe psychiatric or structural brain disease (i.e. psychosis, stroke with functional impairment, dementia) or current/recent risk to self
• Hearing impairment that would impede ability to listen the auditory intervention
• Major illnesses impacting the study results
• For smokers, currently taking Wellbutrin, Chantix, or other pharmacological smoking cessation aids that could confound results of the study

Where it is running

• Stanford Medicine - Psychiatry and Behavioral Sciences — Palo Alto, California, United States
• Dept. of Psychiatry, Stanford University — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.